Video Experimental Relacionado
Updated: Aug 28, 2025
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
Control de la superselectividad de las interacciones multivalentes con los cofactores y los competidores
Tine Curk1, Galina V Dubacheva2, Alain R Brisson3
1Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, United States.
Journal of the American Chemical Society
|September 14, 2022
Resumen
Los cofactores y los competidores modulan las interacciones de unión multivalente simplemente reescalando las afinidades de enlace individuales. Este modelo teórico explica la superselectividad en aplicaciones de reconocimiento biológico y nanomedicina.
Área de la Ciencia:
- La bioquímica
- Biofísica molecular
- Biología Química
Sus antecedentes:
- Las interacciones multivalentes son cruciales en los sistemas biológicos.
- No se comprende bien la influencia de las moléculas competidoras o auxiliares en la unión multivalente.
Objetivo del estudio:
- Desarrollar un modelo teórico que explique cómo los cofactores y los competidores afectan la unión multivalente.
- Investigar la modulación de la superselectividad en las interacciones multivalentes.
Principales métodos:
- Derivación de un modelo teórico para las interacciones multivalentes.
- Reescalado de las constantes de afinidad de enlace ligando-receptor.
- Validación experimental utilizando los sistemas de unión de la anexina A5 y el hialuronano.
Principales resultados:
- Un simple reescalado de las constantes de afinidad capta plenamente el papel de los cofactores y los competidores.
- Las predicciones teóricas se alinean con los datos experimentales de las interacciones entre la anexina A5-lípido y el hialuronano-CD44.
- Se ha demostrado que la superselectividad de las interacciones multivalentes está modulada por las fracciones participantes.
Conclusiones:
- Los hallazgos proporcionan un marco para comprender el reconocimiento multivalente en contextos biológicos.
- Este trabajo ofrece ideas para el diseño de nanosondas multivalentes selectivas en química medicinal.
Videos de Conceptos Relacionados
01:58Cooperative Allosteric Transitions
8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
00:49Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
01:19Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
01:30Enzyme Inhibition
79.1K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.1K
01:25Drug-Receptor Bonds
3.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.2K
01:23Complexation Equilibria: Overview
791
Complexation reactions take place when dative or coordinate covalent bonds form between metal ions and ligands. The compounds formed in these reactions are called coordination compounds. The number of bonds formed between the metal ion and the ligands is called its coordination number. Generally, most metal ions in an aqueous solution are solvated by water molecules and thus exist as aqua complexes.
The equilibrium constant of the complexation reaction is represented as the formation constant...
The equilibrium constant of the complexation reaction is represented as the formation constant...
791